Generated by AI
RxSight, Inc. is a commercial-stage ophthalmic medical technology company focused on improving vision outcomes after cataract surgery. The company’s core offering is the RxSight Light Adjustable Lens system, which includes the Light Adjustable Lens and the Light Delivery Device, along with related accessories used by eye care professionals. This platform allows doctors to customize and optimize a patient’s visual acuity after implantation, addressing a major need in premium cataract care. RxSight serves ophthalmic surgeons, ambulatory surgery centers, and ophthalmology practices, with its products used in the U.S. cataract surgery market and selected international markets through distribution partners. Headquartered in Aliso Viejo, California, RxSight operates as a specialized medical device business centered on adjustable intraocular lens technology and post-surgical vision refinement.
Website100 Columbia
Aliso Viejo, CA, 92656
United States
The latest articles about RXST.
RxSight Inc (RXST) posted $24.6 million in Q3 2026 revenue amid competitive and internal disruption, while completing a restructuring and advancing its Alcon partnership and next-gen lens pipeline.
Summary of Jul 10's posts. Generated by AI.
Summary of Jul 9's posts. Generated by AI.
No summary yet.
Summary of Jul 9's posts. Generated by AI.
Investors talking about RXST also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.